ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 40 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q3 2016. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $38,000 | -38.7% | 29,338 | 0.0% | 0.00% | – |
| Q1 2019 | $62,000 | -6.1% | 29,338 | 0.0% | 0.00% | – |
| Q4 2018 | $66,000 | -35.9% | 29,338 | 0.0% | 0.00% | – |
| Q3 2018 | $103,000 | +9.6% | 29,338 | 0.0% | 0.00% | – |
| Q2 2018 | $94,000 | -8.7% | 29,338 | 0.0% | 0.00% | – |
| Q1 2018 | $103,000 | -20.2% | 29,338 | 0.0% | 0.00% | – |
| Q4 2017 | $129,000 | -15.7% | 29,338 | 0.0% | 0.00% | -100.0% |
| Q3 2017 | $153,000 | 0.0% | 29,338 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $153,000 | +22.4% | 29,338 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $125,000 | +35.9% | 29,338 | 0.0% | 0.00% | – |
| Q4 2016 | $92,000 | -8.9% | 29,338 | 0.0% | 0.00% | – |
| Q3 2016 | $101,000 | +23.2% | 29,338 | 0.0% | 0.00% | – |
| Q2 2016 | $82,000 | – | 29,338 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROW Partners, LLC | 325,000 | $2,077,000 | 1.27% |
| DAFNA Capital Management LLC | 125,000 | $799,000 | 0.82% |
| BARD ASSOCIATES INC | 170,925 | $1,094,000 | 0.46% |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 525,000 | $3,355,000 | 0.36% |
| SOPHROSYNE CAPITAL LLC | 42,000 | $267,000 | 0.23% |
| Granite Point Capital Management, L.P. | 205,000 | $1,310,000 | 0.22% |
| SABBY MANAGEMENT, LLC | 407,024 | $2,601,000 | 0.17% |
| SCOGGIN MANAGEMENT LP | 150,000 | $959,000 | 0.08% |
| Geduld E E | 25,000 | $160,000 | 0.08% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 45,000 | $288,000 | 0.05% |